Product
Buspirone
Aliases
Buspar, Buspirone tablets, 5mg/ tablet, Buspirone tablets mimic, 0mg/ tablet
16 clinical trials
19 indications
Indication
Generalized Anxiety DisorderIndication
Spinal Cord InjuriesIndication
Drug EffectIndication
AnxietyIndication
Opioid Use DisorderIndication
Opioid WithdrawalIndication
Opioid CravingIndication
Traumatic Brain InjuryIndication
Autism Spectrum DisorderIndication
Major Depressive DisorderIndication
TraumaIndication
Spinal Cord InjuryIndication
tetraplegiaIndication
QuadriplegiaIndication
Williams SyndromeIndication
AnhedoniaIndication
ParkinsonIndication
Sleep Disordered BreathingIndication
Able BodiedClinical trial
Safety and Efficacy of Buagafuran Capsules in the Treatment of Generalized Anxiety Disorder: a Multi-center, Randomized, Double-blind, Double-dummy, Placebo-controlled, Positive-controlled, Flexible-dose Phase Ⅲ Clinical TrialStatus: Recruiting, Estimated PCD: 2026-06-30
Clinical trial
Acute Effects of Pharmacological Neuromodulation on Leg Motor Activity in Patients With Spinal Cord Injury Treated With Epidural Electrical StimulationStatus: Completed, Estimated PCD: 2023-10-04
Clinical trial
Measurement of the Hippocampal Theta Rhythm From the Outer Ear CanalStatus: Recruiting, Estimated PCD: 2025-09-01
Clinical trial
Evaluating a Mechanistically-Supported Pharmacotherapy to Treat Opioid WithdrawalStatus: Recruiting, Estimated PCD: 2027-01-31
Clinical trial
Brain Research in Aggression and Irritability Network (BRAIN): Building Evidence-Based Approaches to Managing Traumatic Brain InjuryStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
A Pilot Study of Buspirone for the Treatment of Anxiety in Youth With Autism Spectrum DisordersStatus: Not yet recruiting, Estimated PCD: 2025-08-01
Clinical trial
Transformation of Paraplegic Paralysis to Overground Stepping in HumansStatus: Recruiting, Estimated PCD: 2024-08-31
Clinical trial
Buspirone and Melatonin for Depression Following Traumatic Brain InjuryStatus: Recruiting, Estimated PCD: 2026-07-31
Clinical trial
Enabling Forelimb Function With Agonist Drug and Epidural Stimulation in SCIStatus: Active (not recruiting), Estimated PCD: 2024-12-30
Clinical trial
Buspirone for the Treatment of Anxiety in Williams SyndromeStatus: Completed, Estimated PCD: 2023-09-11
Clinical trial
Serotonin-receptor Agonism in Reward ProcessingStatus: Completed, Estimated PCD: 2023-04-18
Clinical trial
An Open-label Trial of Buspirone for the Treatment of Anxiety in Youth With Autism Spectrum DisordersStatus: Active (not recruiting), Estimated PCD: 2023-12-01
Clinical trial
Buspirone Treatment of Iatrogenic Dyskinesias in Advanced Parkinson' Disease. Multicenter, International, Placebo-controlled, Randomised, Double Blind TrialStatus: Completed, Estimated PCD: 2023-03-23
Clinical trial
Improving Ventilatory Capacity in Those With Chronic High Level SCIStatus: Recruiting, Estimated PCD: 2023-11-29
Clinical trial
Central Sleep Apnea: Physiologic Mechanisms to Inform TreatmentStatus: Recruiting, Estimated PCD: 2025-06-30
Clinical trial
Double-blind Trial of Buspirone for the Treatment of Anxiety in Youth With Autism Spectrum DisordersStatus: Withdrawn, Estimated PCD: 2013-07-01